Tumor PHD2 Expression Is Correlated With Clinical Features and Prognosis of Patients With HCC Receiving Liver Resection-Reference-Cited by-同舟云学术

Tumor PHD2 Expression Is Correlated With Clinical Features and Prognosis of Patients With HCC Receiving Liver Resection

Published:2014-12 Issue:29 Volume:93 Page:e179
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Zhen Li,Shijie Ning,Shuijun Zhang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference40 articles.

1. Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets;Severi;Acta Pharmacol Sin,2010

2. Risk factors associated with hepatocellular carcinoma in primary biliary cirrhosis;Floreani;Hepatology,2013

3. Over-expression of prolyl hydroxylase-1 blocks NF-kappaB-mediated cyclin D1 expression and proliferation in lung carcinoma cells;Xie;Cancer Genet,2014

4. Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growth;Erez;Cancer Res,2003

5. DNA methylation analysis of the HIF-1alpha prolyl hydroxylase domain genes PHD1, PHD2, PHD3 and the factor inhibiting HIF gene FIH in invasive breast carcinomas;Huang;Histopathology,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulation;Oncogene;2022-06-15

2. Liposomal PHD2 Inhibitors and the Enhanced Efficacy in Stabilizing HIF-1α;Nanomaterials;2022-01-03

3. Identification of hub genes and candidate drugs in hepatocellular carcinoma by integrated bioinformatics analysis;Medicine;2021-10-01

4. Systemic long‐term inactivation of hypoxia‐inducible factor prolyl 4‐hydroxylase 2 ameliorates aging‐induced changes in mice without affecting their life span;The FASEB Journal;2020-02-25

5. Cellular and Extracellular Components in Tumor Microenvironment and Their Application in Early Diagnosis of Cancers;Analytical Cellular Pathology;2020-01-08